X4 Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
X4 Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker XFOR.
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis...
Can you invest in X4 Pharmaceuticals, Inc.?
Yes. X4 Pharmaceuticals, Inc. trades publicly on NASDAQ as XFOR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for X4 Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.